Sensus Healthcare, Inc.
SRTS
$3.15
-$0.03-0.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.29% | 24.74% | 71.30% | 65.61% | 21.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.29% | 24.74% | 71.30% | 65.61% | 21.00% |
| Cost of Revenue | 24.19% | 38.32% | 67.97% | 55.86% | 24.78% |
| Gross Profit | -10.51% | 15.82% | 73.75% | 72.54% | 18.63% |
| SG&A Expenses | 47.62% | 34.67% | 12.63% | -19.04% | -20.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.96% | 40.89% | 36.01% | 9.86% | 0.10% |
| Operating Income | -116.00% | -53.01% | 2,206.77% | 767.47% | 277.19% |
| Income Before Tax | -105.17% | -46.36% | 1,285.87% | 1,823.03% | 206.34% |
| Income Tax Expenses | -87.62% | -7.63% | 1,330.72% | 2,289.26% | 297.24% |
| Earnings from Continuing Operations | -112.76% | -61.29% | 1,270.52% | 1,139.17% | 178.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -112.76% | -61.29% | 1,270.52% | 1,139.17% | 178.73% |
| EBIT | -116.00% | -53.01% | 2,206.77% | 767.47% | 277.19% |
| EBITDA | -111.91% | -50.79% | 7,741.28% | 910.81% | 241.02% |
| EPS Basic | -112.72% | -61.32% | 1,281.36% | 1,102.81% | 184.92% |
| Normalized Basic EPS | -105.20% | -46.09% | 1,389.66% | 1,638.32% | 212.19% |
| EPS Diluted | -114.46% | -63.67% | 1,493.28% | 1,026.80% | 193.37% |
| Normalized Diluted EPS | -105.34% | -46.36% | 1,386.21% | 1,568.45% | 217.66% |
| Average Basic Shares Outstanding | 0.28% | 0.32% | 0.33% | -0.01% | -0.40% |
| Average Diluted Shares Outstanding | 0.39% | 0.54% | 0.62% | -0.11% | -0.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |